首页> 外文期刊>Journal of proteome research >Identification of PRDX4 and P4HA2 as metastasis-associated proteins in oral cavity squamous cell carcinoma by comparative tissue proteomics of microdissected specimens using iTRAQ technology
【24h】

Identification of PRDX4 and P4HA2 as metastasis-associated proteins in oral cavity squamous cell carcinoma by comparative tissue proteomics of microdissected specimens using iTRAQ technology

机译:利用iTRAQ技术通过显微组织标本的比较组织蛋白质组学鉴定PRDX4和P4HA2作为口腔鳞状细胞癌转移相关蛋白

获取原文
获取原文并翻译 | 示例
           

摘要

Cervical lymph node metastasis represents the major prognosticator for oral cavity squamous cell carcinoma (OSCC). Here, we used an iTRAQ-based quantitative proteomic approach to identify proteins that are differentially expressed between microdissected primary and metastatic OSCC tumors. The selected candidates were examined in tissue sections via immunohistochemistry, and their roles in OSCC cell function investigated using RNA interference. Seventy-four differentially expressed proteins in nodal metastases, including PRDX4 and P4HA2, were identified. Immunohistochemical analysis revealed significantly higher levels of PRDX4 and P4HA2 in tumor cells than adjacent non-tumor epithelia (P < 0.0001 and P < 0.0001, respectively), and even higher expression in the 31 metastatic tumors of lymph nodes, compared to the corresponding primary tumors (P = 0.060 and P = 0.002, respectively). Overexpression of PRDX4 and P4HA2 was significantly associated with positive pN status (P = 0.048 and P = 0.021, respectively). PRDX4 overexpression was a significant prognostic factor for disease-specific survival in both univariate and multivariate analyses (P = 0.034 and P = 0.032, respectively). Additionally, cell migration and invasiveness were attenuated in OEC-M1 cells upon in vitro knockdown of PRDX4 and P4HA2 with specific interfering RNA. Novel metastasis-related prognostic markers for OSCC could be identified by our approach.
机译:宫颈淋巴结转移是口腔鳞状细胞癌(OSCC)的主要预后指标。在这里,我们使用了基于iTRAQ的定量蛋白质组学方法来鉴定在显微解剖的原发性和转移性OSCC肿瘤之间差异表达的蛋白质。通过免疫组织化学在组织切片中检查选定的候选者,并使用RNA干扰研究其在OSCC细胞功能中的作用。在淋巴结转移中,包括PRDX4和P4HA2的74种差异表达蛋白被鉴定出来。免疫组织化学分析显示,肿瘤细胞中PRDX4和P4HA2的水平明显高于相邻的非肿瘤上皮细胞(分别为P <0.0001和P <0.0001),与相应的原发肿瘤相比,在31个淋巴结转移性肿瘤中的表达甚至更高。 (分别为P = 0.060和P = 0.002)。 PRDX4和P4HA2的过表达与阳性pN状态显着相关(分别为P = 0.048和P = 0.021)。在单变量和多变量分析中,PRDX4过表达是疾病特异性生存的重要预后因素(分别为P = 0.034和P = 0.032)。此外,在体外用特异性干扰RNA敲低PRDX4和P4HA2后,OEC-M1细胞中的细胞迁移和侵袭力减弱。可以通过我们的方法确定OSCC的新型与转移相关的预后指标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号